awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33394153-2C38B87D-1945-4D17-9AFB-9E5215AA3747
Q33394153-2C38B87D-1945-4D17-9AFB-9E5215AA3747
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33394153-2C38B87D-1945-4D17-9AFB-9E5215AA3747
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).
P2860
Q33394153-2C38B87D-1945-4D17-9AFB-9E5215AA3747
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33394153-2C38B87D-1945-4D17-9AFB-9E5215AA3747
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
68acffe35bcf962b2067a0c5aab2db9eafc06d79
P2860
Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia.